KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Total Debt (2016 - 2025)

Historic Total Debt for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Q4 2025 value amounting to $16.8 billion.

  • Teva Pharmaceutical Industries' Total Debt fell 549.4% to $16.8 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $16.8 billion, marking a year-over-year decrease of 549.4%. This contributed to the annual value of $16.8 billion for FY2025, which is 549.4% down from last year.
  • Teva Pharmaceutical Industries' Total Debt amounted to $16.8 billion in Q4 2025, which was down 549.4% from $16.8 billion recorded in Q3 2025.
  • Over the past 5 years, Teva Pharmaceutical Industries' Total Debt peaked at $25.1 billion during Q2 2021, and registered a low of $16.7 billion during Q1 2025.
  • Over the past 5 years, Teva Pharmaceutical Industries' median Total Debt value was $20.3 billion (recorded in 2023), while the average stood at $20.4 billion.
  • Its Total Debt has fluctuated over the past 5 years, first plummeted by 428.3% in 2021, then plummeted by 1523.62% in 2025.
  • Teva Pharmaceutical Industries' Total Debt (Quarter) stood at $23.0 billion in 2021, then fell by 7.95% to $21.2 billion in 2022, then decreased by 6.5% to $19.8 billion in 2023, then decreased by 10.34% to $17.8 billion in 2024, then decreased by 5.49% to $16.8 billion in 2025.
  • Its Total Debt stands at $16.8 billion for Q4 2025, versus $16.8 billion for Q3 2025 and $17.2 billion for Q2 2025.